SCHEMBL24919232

SCHEMBL24919232

CB[SH](C)(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2709130 0.58
SCHEMBL172102 0.53
Ammonia Solution, Strong SCHEMBL10611826 0.47
Hydrogen Sulfide SCHEMBL2121945 0.47
SCHEMBL14351100 0.47
SCHEMBL6897693 0.47
SCHEMBL10039326 0.47
SCHEMBL14206818 0.47
SCHEMBL22415851 0.47
Bromide SCHEMBL9080847 0.47

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230027965-A1 METHODS OF TREATING HIV-1 INFECTION UTILIZING BROADLY NEUTRALIZING HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GP120-SPECIFIC MONOCLONAL ANTIBODIES THE SCRIPPS RESEARCH INSTITUTE 2023-01-26 US disclosed